Learning Objectives
Upon completion of this activity, participants should be able to:
- Incorporate evolving data on the targeted treatment of metastatic CRC into clinical practice to optimize patient outcomes
- Apply predictive and prognostic tests in the clinical management of patients with CRC
- Manage the adverse events associated with chemotherapeutic treatment of colorectal cancer
- Interpret current data on adjuvant therapies for patients with CRC
- Analyze the role of tumor KRAS mutation status as a predictor of response to anti-EGFR therapy in patients with metastatic CRC
Topics covered include:
- Case 1: Stage II Colon Cancer
- Case 1: Role of Predictive and Prognostic Tests in Stage II Colon Cancer
- Case 1: Role of Exercise and Aspirin in Patients With Stage II Colon Cancer
- Case 1: Patient Education and Follow-up
- Case 2: Metastatic, Borderline-Resectable Colorectal cancer
- Case 2: Choosing a Chemotherapy Regimen
- Case 2: Choosing a Biologic Agent
- Case 2: Postoperative Adjuvant Therapy and Surveillance
- Case 3: Unresectable Metastatic Colorectal Cancer
- Case 3: Managing Chemotherapy Adverse Events